×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Is Madrigal Pharmaceuticals Stock a Buy?
Nasdaq
Madrigal Pharmaceuticals' (NASDAQ: MDGL) shares are down by 27% over the past year, while the S&P 500 is up by 26%.
2 days ago
Synta Stock Up on Merger Deal with Madrigal Pharmaceuticals
Yahoo News Singapore
Synta (SNTA) announced all-stock merger transaction with Madrigal Pharmaceuticals to create a company focused on cardiovascular-metabolic...
1 day ago
Madrigal Pharma surges after drug wins first approval for fatty liver disease NASH
Reuters
Madrigal Pharmaceuticals shares jumped as much as 23% on Friday after its oral drug became the first approved treatment for a fatty liver...
2 months ago
Is Madrigal Pharmaceuticals Stock a Buy?
MSN
Madrigal Pharmaceuticals' (NASDAQ: MDGL) shares are down by 27% over the past year, while the S&P 500 is up by 26%.
2 days ago
Madrigal builds launch infrastructure for MASH drug Rezdiffra
Fierce Pharma
'Remarkable interest': Madrigal touts early launch progress for first MASH drug Rezdiffra despite VA hurdle ... With $1.1 billion cash on Madrigal...
2 weeks ago
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
CNBC
Madrigal's drug, which will be marketed as Rezdiffra, is specifically approved to treat patients with NASH who also have moderate-to-advanced...
2 months ago
Charles Schwab Investment Management Inc. Raises Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
MarketBeat
Charles Schwab Investment Management Inc. boosted its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 9.8% during...
9 hours ago
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
The Motley Fool
This means that over the long term, Madrigal's rate of growth may slow as it faces more competition. But that's a concern to be thinking about a...
1 month ago
Madrigal Pharmaceuticals Soars After Getting FDA Approval for Liver-Scarring Treatment
Investopedia
Key Takeaways · The Food and Drug Administration (FDA) gave accelerated approval for Madrigal Pharmaceuticals Inc.'s drug to treat scarring from...
2 months ago
Is Madrigal Pharmaceuticals Stock a Buy?
sharewise
Madrigal Pharmaceuticals' (NASDAQ: MDGL) shares are down by 27% over the past year, while the S&P 500 is up by 26%.
2 days ago